Millions of Australians will benefit from cost-of-living relief as the Albanese Labor Government announces a freeze in the maximum cost of Pharmaceutical Benefits Scheme medicines. Medicines will be frozen at $25 until 2030.
National President of the Pharmacy Guild of Australia, Professor Trent Twomey, said the freeze was a major win for patients and families managing pressure on household budgets.
“This is great news for every Australian who needs essential medicines. People can delay a holiday or a new television, but they should never have to delay treatment for diabetes, asthma or high blood pressure because the family budget does not stretch far enough.
“This is the first ever freeze of the general co-payment in the history of the PBS. It follows two historic price cuts to PBS medicines, which have saved patients $1.5bn since 2023.
“The price of medicine is now the same as in 2004 – and will stay the same price until 2030.
The announcement followed research showing 85% of Australians supported a freeze in the general co-payment.
“The Albanese Labor Government has listened to Australians and delivered practical relief that will make a genuine difference in households across the country.
“Affordable medicines help people begin their treatment, stay on it and protect their health. This decision puts patients first, and the Government deserves enormous credit for delivering it.”
The maximum general PBS co-payment was reduced from $31.60 to $25 on 1 January 2026, taking the maximum price of PBS medicines for general patients to its lowest level in 20 years. Without further government action, the co-payment was due to begin rising with indexation from 1 January 2027.
Professor Twomey thanked the Government and the patients, pharmacists, health advocates and parliamentarians who shared their concerns about the impact of rising medicine prices.